Home > Insider Trading > Filing (0001209191-18-004433)

Filing Details

Accession Number:: 0001209191-18-004433
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-01-18 21:30:59
Reporting Period:: 2018-01-16

Accepted Time:: 2018-01-18 21:30:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1594864	Juno Therapeutics Inc.	JUNO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1480212	Edgar Hans Bishop	C/O 400 Dexter Avenue North Suite 1200 Seattle WA 98109	Ceo & President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-01-16	245,750	$6.36	2,772,679	No	4	M	Direct
Common Stock	Disposition	2018-01-16	65,820	$44.72	2,706,859	No	4	S	Direct
Common Stock	Disposition	2018-01-16	89,888	$45.53	2,616,971	No	4	S	Direct
Common Stock	Disposition	2018-01-16	49,082	$46.52	2,567,889	No	4	S	Direct
Common Stock	Disposition	2018-01-16	23,003	$47.69	2,544,886	No	4	S	Direct
Common Stock	Disposition	2018-01-16	42,457	$48.56	2,502,429	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-01-16	245,750	$0.00	245,750	$6.36

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
451,756		2024-09-08	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2016, as amended March 14, 2017.
This transaction was executed in multiple trades at prices ranging from $44.13 to $45.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $45.13 to $46.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $46.13 to $47.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $47.13 to $48.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $48.13 to $48.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
1/48th of the shares subject to the option became vested and exercisable on October 9, 2014 and 1/48th of the shares subject to the option vested monthly thereafter.